CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Myricx Bio to be Acquired by Novartis to Advance Next-Generation ADC Payloads for Oncology with Novel NMTi Platform

Positive
AI Analysis

Summary

Novartis to acquire Myricx Bio to advance next-generation antibody-drug conjugate (ADC) payloads for oncology using the novel NMTi platform.

Importance:7/10
Sentiment:
0.70
M&AoncologyADCNMTi platformacquisition
Related Companies

Read the original article

Published by yahoo_finance on July 6, 2026 5:05 AM

Read Original